Stock Market Today: Dr Reddy's Laboratories share price declined more than 6% in the morning trades on Friday post-Q3 results that were announced after the market hours of Thursday. On Thursday ...

DRL Share Price: Dr. Reddy’s Laboratories shares fell by 6.2%, hitting an intraday low of Rs 1,209.70 on the BSE on Friday, January 24, following the release of its Q3 FY25 earnings report. The pharma ...

(Reuters) -Shares of Dr Reddy's Laboratories dropped 6% on Friday and were on track for their worst session in nearly nine months, after missing its third-quarter profit estimates on lower sales ...

Hyderabad: Dr D. Nageshwar Reddy, founder and chairman of AIG Hospitals, on Saturday became the first medical doctor to be bestowed with all three Padma awards — Padma Shri in 2002, Padma ...

Shares of Dr. Reddy's Laboratories Ltd. declined over 5% during Friday's early trading session after the company announced its December quarter results. The Q3 earnings revealed subdued numbers and ...

India's Dr Reddy's Laboratories has joined the growing list of pharma companies that are looking to tap into the market for medical cannabis, buying German developer Nimbus Health for an ...

(Image: Freepik) Dr Reddy’s Lab share prices fell 5.5% to a low of Rs 1,218 as soon as the scrip started trading on the National Stock Exchanges on January 24. The dip in the share price of Dr ...

Dr. Reddy's Laboratories shares fell by 6.2% after the company reported a marginal 2% YoY growth in Q3 FY25 net profit to Rs 1,413 crore. Despite robust revenue growth, Jefferies, Nuvama, and DAM ...

While drugmaker Dr Reddy's Laboratories' Q3 earnings were slightly above the Street's estimates, the highlight of the show was declining revenue contribution from Revlimid, which also weighed on ...